Affiliation:
1. Federal State Budgetary Educational Institution “A.V. Vishnevskiy National Medical Research Center of Surgery” of the Ministry of Healthcare of the Russian Federation
2. Federal State Budgetary Educational Institution “A.V. Vishnevskiy National Medical Research Center of Surgery” of the Ministry of Healthcare of the Russian Federation;
Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation
Abstract
HighlightsThe feasibility and safety of stereotactic radioablation of arrhythmias have been actively investigated over the last few years. Stereotactic radioablation is an innovative approach for the noninvasive treatment of sustained arrhythmias in high-risk patients. A comprehensive analysis of the advantages and disadvantages of this STAR in relation to AF will allow us to assess the future prospects for the development of this area. AbstractAtrial fibrillation is the most common tachyarrhythmia. The prevalence of this arrhythmia continues to increase steadily due to the rapid demographic ageing of the population. In addition, patients with concomitant cancer are often affected by AF.Despite the relatively benign course of AF, this arrhythmia is a risk factor for the development of a number of life-threatening and disabling complications, which significantly reduces the quality of life and increases the costs to the health care system.For a long time, non-invasive methods of AF treatment were represented exclusively by antiarrhythmic therapy. It is important to note that in elderly and oncological patients, even paroxysmal AF is difficult to treat with medication, and catheter ablation and surgery are associated with high risks of procedural and early postoperative complications.All this served to search for noninvasive methods of ablation of arrhythmogenic substrates of AF. For the first time, stereotactic radioablation was used in clinical practice to eliminate sustained ventricular tachyarrhythmias. Having accumulated sufficient experience, the scientists decided to consider the application of this non-invasive therapy in patients with AF. Currently, there are sporadic papers and clinical case series highlighting the efficacy and safety of stereotactic radioablation in the treatment of AF.The main aim of the presented literature review was to highlight recent data on the capabilities and limitations of non-invasive radiotoxic stereoablation in patients with AF.
Reference49 articles.
1. Аракелян, М.Г. Фибрилляция и трепетание предсердий. Клинические рекомендации 2020 / М.Г. Аракелян, Л.А. Бокерия, Е.Ю. Васильева, С.П. Голицын, Е.З. Голухова, А.Ш. Ревишвили и др. // Российский кардиологический журнал. – 2021. – Т. 26. - №7. – С. 4594. https://doi.org/10.15829/1560-4071-2021-4594
2. Шапкина, М.Ю. Динамика частоты фибрилляции предсердий в российской популяционной выборке за 13 лет наблюдения / М.Ю. Шапкина, Е.В. Маздорова, Е.М. Авдеева и др. // Кардиоваскулярная терапия и профилактика. – 2022. - №21(8). – С. 3108. https://doi.org/10.15829/1728-8800-2022-3108
3. Стребкова Е.Д., Ревишвили А.Ш., Малышенко Е.С., Артюхина Е.А., Попов В.А., Новиков М.А., Ялова Е.В., Бондурко К.Э., Кармазановский Г.Г., Кадырова М. Отдаленные результаты торакоскопического лечения фибрилляции предсердий. Вестник аритмологии. 2023;30(2):59-69. https://doi.org/10.35336/VA-2023-2-08
4. Сердечная, Е.В. Особенности распространенности и течения фибрилляции предсердий на северо-западе Российской Федерации / Е.В. Сердечная, Б.А. Татарский, Е.В. Казакевич // Клиническая медицина. – 2009. – Т. 87. - № 1. – С. 17-20
5. Krijthe, B.P. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060 / B.P. Krijthe, A. Kunst, E.J. Benjamin, G.Y. H. Lip, O.H. Franco, A. Hofman, J.C.M. Witteman, B.H. Stricker, J. Heeringa // Eur Heart J. – 2013. – Vol. 34. - №35. – P. 2746-2751. https://doi.org/10.1093/eurheartj/eht280.